Authored By: Sarah
11 Jul 2024

 Pharmaceutical Excipients Market Size to grow by USD 4501.1 million between 2024-2028

According to a research report “ Pharmaceutical Excipients Market” by Type (Organic, Inorganic) Product (Binders and fillers, Coating agents, Disintegrants, Others) Geography (North America, Europe, APAC, South America, Middle East and Africa)- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 4501.1 million, at a CAGR of almost 7.17% during the forecast period. Functional excipients play a crucial role in the pharmaceutical industry, as they enhance the efficacy and safety of pharmaceutical formulations. The market for functional excipients is projected to grow significantly during the forecast period, driven by their application in advanced drug delivery systems. Innovative companies are leveraging cutting-edge technologies to develop new excipient formulations, adhering to industry standards and good manufacturing practices. The emergence of new compositions of ingredients in generic drugs, particularly oral dispersible tablets, is contributing to controlled release and improved patient compliance. In the long term, nanotechnology and biotechnology are expected to revolutionize the excipient industry by enabling the creation of novel formulations and delivery systems.

Browse market data tables, figures, and in-depth TOC on “Pharmaceutical Excipients Market” by Type (Organic, Inorganic) Product (Binders and fillers, Coating agents, Disintegrants, Others) Geography (North America, Europe, APAC, South America, Middle East and Africa) Global Forecast to 2028. Download Free Sample


By Type, the Organic segment is projected to dominate the market size in 2024

In the pharmaceutical industry, excipients play a crucial role in the formulation of drugs. Fillers, specifically, serve the purpose of increasing the mass of a medication without altering its active properties. Ideally, fillers should be non-hygroscopic, cost-effective, tasteless, or have a pleasant taste, and be compatible with other drug components. Commonly used fillers include plant cellulose, calcium phosphate, and vegetable fats and oils, which are particularly preferred in soft gelatin capsules. Additionally, lactose, sucrose, glucose, sorbitol, calcium carbonate, and magnesium stearate are other types of fillers utilized. Simultaneously, binders are essential excipients that ensure the cohesion of drug ingredients in tablets. They add volume to low-active-dose tablets and provide the necessary mechanical strength. It is imperative that binders are compatible with other components in a drug formulation and offer sufficient consistency to powders to maintain the desired tablet structure. Common binders include hydroxypropyl methylcellulose, polyvinylpyrrolidone, and starch.

By Product, Binders and fillers  segment is expected to hold the largest market size for the year 2024

In the pharmaceutical industry, organically derived excipients play a significant role in the formulation of medications. These excipients include oleochemicals, carbohydrates, proteins, and others. Oleochemical-based excipients, such as fatty alcohols, mineral stearates, and glycerin, are commonly used. On the other hand, carbohydrate-based excipients, including sugars, sugar alcohols, artificial sweeteners, cellulose, starch, and petrochemicals, are also widely employed. Specifically, petrochemicals encompass glycols (polyethylene glycol and propylene glycol), povidones, mineral hydrocarbons (petrolatum, mineral waxes, and mineral oils), and acrylic polymers. These excipients contribute to the stability, consistency, and bioavailability of pharmaceutical formulations.

North America is forecasted to hold the largest market size by region in 2024

The Pharmaceutical Excipients Market represents a significant segment in the healthcare industry. These essential components, excluding active pharmaceutical ingredients, contribute to enhancing the therapeutic efficacy, safety, and patient compliance of pharmaceutical formulations. Market growth is driven by factors such as increasing demand for cost-effective and efficient drugs, rising prevalence of chronic diseases, and stringent regulatory requirements. Key players in this market focus on innovation, product development, and strategic collaborations to cater to evolving consumer needs and regulatory standards.

The Pharmaceutical Excipients Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Actylis
  • Air Liquide SA
  • Archer Daniels Midland Co.
  • Ashland Inc.
  • Associated British Foods Plc
  • Avantor Inc.
  • Colorcon Inc.
  • Croda International Plc
  • DFE Pharma GmbH and Co. KG
  • Dow Chemical Co.
  • Evonik Industries AG
  • Innophos Holdings Inc.
  • J M Huber Corp.
  • JRS PHARMA GmbH and Co. KG
  • Kerry Group Plc
  • Merck and Co. Inc.
  • Roquette Freres SA
  • The Lubrizol Corp.
  • Wacker Chemie AG

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Pharmaceutical Excipients Market encompasses a wide range of inactive ingredients used in the production of various dosage forms, including coating agents, suspending & viscosity agents, fillers & diluents, lubricants, and glidants. Coating agents improve the aesthetic appeal and functionality of tablets and capsules, while suspending & viscosity agents ensure the uniform dispersion of active pharmaceutical ingredients in liquid formulations. The market caters to diverse pharmaceutical formulations such as parenteral, topical, and oral, including capsules, tablets, and liquid formulations. Excipient manufacturers focus on developing single function excipients as well as enhanced functionality excipients through physical processes and co-processed multifunctional excipients. Regulatory agencies like the FDA and EMA have stringent approval processes for excipients, which can increase development costs. However, customized excipient solutions, collaborations, and investments in novel excipients are driving innovation in the market. The market is segmented into oral formulations, with a significant share held by capsules and tablets. The market is also influenced by the increasing demand for patient-centric formulations, R&D investments, and the growth of generic drugs.

Market Research Overview

The Pharmaceutical Excipients Market is witnessing significant growth due to the increasing demand for Nutroféli ST300, ST200, and ST100 from excipient manufacturers. These products, manufactured by Beneo, are derived from hydroxypropyl methylcellulose (HPMC) and are widely used as binders, disintegrants, and suspension agents in various dosage forms. Other popular excipients include polyvinylpyrrolidone (PVD) for coating agents and suspending agents, gelatin for capsule shells and tablet coatings, starch for disintegrants and binders, and emulsifying agents, preservatives, colorants, flavoring agents & sweeteners, fillers & diluents, lubricants and glidants for various formulation properties. The market for pharmaceutical excipients is diverse, catering to various dosage forms such as parenteral formulations, topical formulations, liquid formulations, capsules, and tablets. The Oral Formulations segment holds the largest market share. The stringent regulatory requirements set by regulatory bodies like the USFDA and other agencies pose a challenge for excipient manufacturers, requiring innovation, complexity, and efficacy in formulation properties and manufacturing processes. Single function excipients are being replaced by co-processed multifunctional excipients to enhance functionality and reduce manufacturing costs. New excipients are under development, with a focus on customized excipient solutions, collaborations, and novel excipients. The approval process and regulatory stringency add to the development costs and high investments in R&D. Despite these challenges, the pharmaceutical industry continues to invest in excipients to improve the performance, safety, and patient-centric formulations of drug products, including generic drugs.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!